UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis

British journal of dermatology (1951), 2016-06, Vol.174 (6), p.1266-1276

2016

Volltextzugriff (PDF)

Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States

Osteoporosis international, 2017-03, Vol.28 (3), p.799-809

2017

Volltextzugriff (PDF)

Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of Raloxifene

JNCI : Journal of the National Cancer Institute, 2004-12, Vol.96 (23), p.1751-1761

2004

Volltextzugriff (PDF)

A Role for Sp and Nuclear Receptor Transcription Factors in a Cardiac Hypertrophic Growth Program

Proceedings of the National Academy of Sciences - PNAS, 1997-06, Vol.94 (12), p.6438-6443

1997

Volltextzugriff (PDF)

395 Nail psoriasis as a predictor of skin response to ixekizumab in patients with moderate-to-severe psoriasis

Journal of investigative dermatology, 2018-05, Vol.138 (5), p.S67-S67

2018

Volltextzugriff (PDF)

Transcriptional control of a nuclear gene encoding a mitochondrial fatty acid oxidation enzyme in transgenic mice: role for nuclear receptors in cardiac and brown adipose expression

Molecular and Cellular Biology, 1996-08, Vol.16 (8), p.4043-4051

1996

Volltextzugriff (PDF)

Safety assessment of raloxifene over eight years in a clinical trial setting

Current medical research and opinion, 2005-09, Vol.21 (9), p.1441-1452

2005

Volltextzugriff (PDF)

Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas

International journal of biological sciences, 2012-01, Vol.8 (10), p.1363-1374

2012

Volltextzugriff (PDF)

Managing chronic atrial fibrillation: a Markov decision analysis comparing warfarin, quinidine, and low-dose amiodarone

Annals of internal medicine, 1994-03, Vol.120 (6), p.449

1994

Volltextzugriff (PDF)

Evaluating suicide-related adverse events in clinical trials of fluoxetine treatment in adults for indications other than major depressive disorder

Psychological medicine, 2007-11, Vol.37 (11), p.1585-1593

2007

Volltextzugriff (PDF)

Changes in patients undergoing coronary artery bypass grafting: 1987–1990

The Annals of thoracic surgery, 1994-02, Vol.57 (2), p.416-423

1994

Volltextzugriff (PDF)

Effect of raloxifene on invasive breast cancer incidence in postmenopausal women stratified by age (< 65 and ≥ 65 years)

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.1009-1009

2005

Volltextzugriff (PDF)

Therapeutic strategies for atrial fibrillation. The value of decision analysis

Cardiology clinics, 1996-11, Vol.14 (4), p.623-640

1996

Volltextzugriff (PDF)

RESPONSE: Re: Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of Raloxifene

JNCI : Journal of the National Cancer Institute, 2005-04, Vol.97 (7), p.542-543

2005

Volltextzugriff (PDF)

Incidence of invasive breast cancer following 8 years of raloxifene therapy in postmenopausal women with osteoporosis: Results from the Continuing Outcomes Relevant to Evista (CORE) trial

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.1000-1000

2004

Volltextzugriff (PDF)

Effect of raloxifene on invasive breast cancer incidence in postmenopausal women stratified by Gail risk assessment: Results of the Continuing Outcomes Relevant to Evista (CORE) trial

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.1018-1018

2004

Volltextzugriff (PDF)

Incidence of invasive breast cancer following 8 years of raloxifene therapy in postmenopausal women with osteoporosis: Results from the Continuing Outcomes Relevant to Evista (CORE) trial

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.1000-1000

2004

Volltextzugriff (PDF)

Effect of raloxifene on invasive breast cancer incidence in postmenopausal women stratified by Gail risk assessment: Results of the Continuing Outcomes Relevant to Evista (CORE) trial

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.1018-1018

2004

Volltextzugriff (PDF)

Changes in patients undergoing coronary artery bypass grafting: 1987-1990. Northern New England Cardiovascular Disease Study Group

The Annals of thoracic surgery, 1994-02, Vol.57 (2), p.416-423

1994

Volltextzugriff (PDF)

Bayesian Nonparametric Inference for Effective Doses in a Quantal-Response Experiment

Biometrics, 1981-12, Vol.37 (4), p.713-722

Disch, Damon

1981

Volltextzugriff (PDF)

Creating an awareness of expert systems at Encore Computer Corporation: a case study

Proceedings [1990] IEEE Conference on Managing Expert System Programs and Projects, 1990, p.156-159

1990

Volltextzugriff (PDF)

Management of atrial fibrillation

Annals of internal medicine, 1994-09, Vol.121 (6), p.466; author reply 467

1994

Volltextzugriff (PDF)

Efficacy of two 65% permethrin spot-on formulations against induced infestations of Ctenocephalides felis (Insecta: Siphonaptera) and Amblyomma americanum (Acari: Ixodidae) on beagles

Veterinary therapeutics, 2003, Vol.4 (1), p.47

2003

Volltextzugriff (PDF)

Repellency and efficacy of a 65% permethrin spot-on formulation for dogs against Aedes aegypti (Diptera: Culicidae) mosquitoes

Veterinary therapeutics, 2003, Vol.4 (2), p.135

2003

Volltextzugriff (PDF)

Intranasal Efudix reduces epistaxis in hereditary hemorrhagic telangiectasia

Angiogenesis (London), 2020-08, Vol.23 (3), p.271-274

2020

Volltextzugriff (PDF)

1 – 25 von 177

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(147)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis

Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States

Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of Raloxifene

A Role for Sp and Nuclear Receptor Transcription Factors in a Cardiac Hypertrophic Growth Program

395 Nail psoriasis as a predictor of skin response to ixekizumab in patients with moderate-to-severe psoriasis

Transcriptional control of a nuclear gene encoding a mitochondrial fatty acid oxidation enzyme in transgenic mice: role for nuclear receptors in cardiac and brown adipose expression

Safety assessment of raloxifene over eight years in a clinical trial setting

Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas

Managing chronic atrial fibrillation: a Markov decision analysis comparing warfarin, quinidine, and low-dose amiodarone

Evaluating suicide-related adverse events in clinical trials of fluoxetine treatment in adults for indications other than major depressive disorder

Changes in patients undergoing coronary artery bypass grafting: 1987–1990

Effect of raloxifene on invasive breast cancer incidence in postmenopausal women stratified by age (< 65 and ≥ 65 years)

Therapeutic strategies for atrial fibrillation. The value of decision analysis

RESPONSE: Re: Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of Raloxifene

Incidence of invasive breast cancer following 8 years of raloxifene therapy in postmenopausal women with osteoporosis: Results from the Continuing Outcomes Relevant to Evista (CORE) trial

Effect of raloxifene on invasive breast cancer incidence in postmenopausal women stratified by Gail risk assessment: Results of the Continuing Outcomes Relevant to Evista (CORE) trial

Incidence of invasive breast cancer following 8 years of raloxifene therapy in postmenopausal women with osteoporosis: Results from the Continuing Outcomes Relevant to Evista (CORE) trial

Effect of raloxifene on invasive breast cancer incidence in postmenopausal women stratified by Gail risk assessment: Results of the Continuing Outcomes Relevant to Evista (CORE) trial

Changes in patients undergoing coronary artery bypass grafting: 1987-1990. Northern New England Cardiovascular Disease Study Group

Bayesian Nonparametric Inference for Effective Doses in a Quantal-Response Experiment

Creating an awareness of expert systems at Encore Computer Corporation: a case study

Management of atrial fibrillation

Efficacy of two 65% permethrin spot-on formulations against induced infestations of Ctenocephalides felis (Insecta: Siphonaptera) and Amblyomma americanum (Acari: Ixodidae) on beagles

Repellency and efficacy of a 65% permethrin spot-on formulation for dogs against Aedes aegypti (Diptera: Culicidae) mosquitoes

Intranasal Efudix reduces epistaxis in hereditary hemorrhagic telangiectasia

Suchergebnisse filtern